PCN24 Disease-Free Survival (DFS) As a Surrogate Endpoint for Overall Survival (OS) in HER2 Negative (HER2–) Primary Breast Cancer (BC)
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.161
https://www.valueinhealthjournal.com/article/S1098-3015(20)32417-7/fulltext
Title :
PCN24 Disease-Free Survival (DFS) As a Surrogate Endpoint for Overall Survival (OS) in HER2 Negative (HER2–) Primary Breast Cancer (BC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32417-7&doi=10.1016/j.jval.2020.08.161
First page :
Section Title :
Open access? :
No
Section Order :
10121